Sekhar Surapaneni

Regulatory Drug Disposition and NDA Package Including MIST

Sekhar Surapaneni, 2012 .

ADME-enabling technologies in drug design and development

Sekhar Surapaneni, Donglu Zhang, S. Surapaneni, 2012 .

Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: a case study.

Ping Gao, Sekhar Surapaneni, P. Gao, 2008, Molecular pharmaceutics.

The co-crystal approach to improve the exposure of a water-insoluble compound: AMG 517 sorbic acid co-crystal characterization and pharmacokinetics.

Sekhar Surapaneni, Sesha Neervannan, R. Syed, 2008, Journal of pharmaceutical sciences.

Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans

Mark J. Rose, Andrej A. Romanovsky, A. A. Romanovsky, 2008, PAIN.

Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption.

Ping Gao, Sekhar Surapaneni, P. Gao, 2009, Journal of pharmaceutical sciences.